Diagnosis of Pleural Effusions

Hospital Medicine Clinics

Volumn 2, Issue 3, 2013, Pages

  Porcel, José M ^a  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

Exudate; Malignant pleural effusion; Pleural effusion; Thoracentesis; Transudate

Indexed keywords

ADENOSINE DEAMINASE; ALBUMIN; LACTATE DEHYDROGENASE;

BACTERIAL INFECTION; CHEST TUBE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CYTOPATHOLOGY; HEART FAILURE; HUMAN; LYMPHOMA; NEOPLASM; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; REVIEW; THORACOCENTESIS; TRANSTHORACIC ECHOCARDIOGRAPHY; TUBERCULOUS PLEURISY;

EID: 84879784223     PISSN: 22115943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehmc.2013.02.001     Document Type: Review

References (58)

1. Noppen M. Normal physiological fluid and cellular contents. Textbook of pleural diseases 2008, 39-42. Hodder Arnold, London. 2nd edition. R.W. Light, Y.C. Gary Lee (Eds.).
2. Light R.W. Pleural diseases 2013, Lippincott Williams & Wilkins, Philadelphia. 6th edition.
3. Marel M. Epidemiology of pleural effusion. Eur Respir Mon 2002, 7:146-156.
4. Porcel J.M., Light R.W. Pleural effusions. Dis Mon 2013, 59:29-57.
5. World Health Organization 2012. Global tuberculosis report 2012. Available at: http://www.who.int/tb/publications/global_report/en/.
6. Peto H.M., Pratt R.H., Harrington T.A., et al. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009, 49:1350-1357.
7. Valdés L., Ferreiro L., Cruz-Ferro E., et al. Recent epidemiological trends in tuberculous pleural effusion in Galicia, Spain. Eur J Intern Med 2012, 23:727-732.
8. Haber S.E., Haber J.M. Malignant mesothelioma: a clinical study of 238 cases. Ind Health 2011, 49:166-172.
9. Roberts M.E., Neville E., Berrisford R.G., et al. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax 2010, 65(Suppl 2):ii32-ii40.
10. Segal A., Sterrett G.F., Frost F.A., et al. Adiagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit. Pathology 2013, 45:44-48.
11. Porcel J.M., Light R.W. Diagnostic approach to pleural effusions in adults. Am Fam Physician 2006, 73:1211-1220.
12. Latagliata R, Breccia M, Fava C, et al. Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patient with chronic myelogenous leukaemia. Hematol Oncol, in press.
13. Borasio P., Berruti A., Billé A., et al. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg 2008, 33:307-313.
14. Porcel J.M. Pleural effusions from congestive heart failure. Semin Respir Crit Care Med 2010, 31:689-697.
15. Wong C.L., Holroyd-Leduc J., Strauss S.E. Does this patient have a pleural effusion?. JAMA 2009, 301:309-317.
16. Porcel J.M., Vives M. Etiology and pleural fluid characteristics of large and massive effusions. Chest 2003, 124:978-983.
17. Puchalski J.T., Argento A.C., Murphy T.E., et al. Etiologies of bilateral pleural effusions. Respir Med 2013, 107:284-291.
18. Porcel J.M., Civit M.C., Bielsa S., et al. Contarini's syndrome: bilateral pleural effusion, each side from different causes. JHosp Med 2012, 7:164-165.
19. Falguera M., Carratalá J., Bielsa S., et al. Predictive factors, microbiology and outcomeof patients with parapneumonic effusion. Eur Respir J 2011, 38:1173-1179.
20. Reissig A., Copetti R., Mathis G., et al. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest 2012, 142:965-972.
21. Brixey A.G., Luo Y., Skouras V., et al. The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology 2011, 16:1000-1004.
22. Mortensen C., Bhatnagar R., Edey A.J. Imaging the pleura. Br J Hosp Med 2012, 73:626-632.
23. Sharif S., Zahid I., Routhledge T., et al. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?. Interact Cardiovasc Thorac Surg 2011, 12:806-811.
24. Porcel J.M., Light R.W. Thoracentesis. PIER [online database] 2013, American College of Physicians, Philadelphia, Available at:, Accessed October 28, 2004. http://pier.acponline.org.
25. Koenig S.J., Narasimhan M., Mayo P.H. Thoracic ultrasonography for the pulmonary specialist. Chest 2011, 140:1332-1341.
26. Gordon C.E., Feller-Kopman D., Balk E.M., et al. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med 2010, 170:332-339.
27. Porcel J.M. The diagnostic utility of pleural fluid tests in clinical practice. Curr Respir Med Rev 2012, 8:383-390.
28. Light R.W., MacGregor M.I., Luchsinger P.C., et al. Pleural effusions: the diagnostic separation of transudates and exudates. Arch Intern Med 1972, 77:507-513.
29. Bielsa S., Porcel J.M., Castellote J., et al. Solving the Light's criteria misclassification rate of cardiac and hepatic transudates. Respirology 2012, 17:721-726.
30. Porcel J.M., Esquerda A., Martínez M., et al. Influence of pleural fluid red blood cellcount on the misidentification of transudates. Med Clin (Barc) 2008, 131:770-772.
31. Porcel J.M. Pleural fluid biomarkers. Beyond the Light criteria. Clin Chest Med 2013, 34(1):27-37.
32. Oba Y., Abu-Salah T. The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration 2012, 83:198-208.
33. Rahman N.M., Mishra E.K., Davies H.E., et al. Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. Am J Respir Crit Care Med 2008, 178:483-489.
34. Porcel J.M., Esquerda A., Falguera M., et al. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. Eur J Intern Med 2012, 23:447-450.
35. Porcel J.M. Tuberculous pleural effusion. Lung 2009, 187:263-270.
36. Zhou Q., Chen Y.Q., Qin S.M., et al. Diagnostic accuracy of T-cell interferon-γ release assays in tuberculous pleurisy: a meta-analysis. Respirology 2011, 16:473-480.
37. Bielsa S., Palma R., Pardina M., et al. Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions. Int J Tuberc Lung Dis 2013, 17:85-89.
38. Seiscento M., Vargas F.S., Bombarda S., et al. Pulmonary involvement in pleural tuberculosis: how often does it mean disease activity?. Respir Med 2011, 105:1079-1083.
39. Ruan S.Y., Chuang Y.C., Wang J.Y., et al. Revisiting tuberculous pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area. Thorax 2012, 67:822-827.
40. Porcel J.M., Esquerda A., Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med 2010, 21:419-423.
41. Porcel J.M. Pearls and myths in pleural fluid analysis. Respirology 2011, 16:44-52.
42. Canesa P.A., Franceschini M.C., Ferro P., et al. Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology. Cancer Invest 2013, 31:48-55.
43. Thomas S.C., Davidson L.R., McKean M.E. An investigation of adequate volume for the diagnosis of malignancy in pleural fluids. Cytopathology 2011, 22:179-183.
44. Menzies S.M., Rahman N.M., Wrightson J.M., et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 2011, 66:658-662.
45. Tobin C.L., Porcel J.M., Wrightson J.M., et al. Diagnosis of pleural infection: State of the art. Curr Respir Care Rep 2012, 1:101-110.
46. Porcel JM, García-Gil D. Emergencies in pleural diseases. Rev Clin Esp, in press.
47. Sahn S.A. Getting the most from pleural fluid analysis. Respirology 2012, 17:270-277.
48. Loddenkemper R., Mathur P., Noppen M., et al. Medical thoracoscopy/pleuroscopy: manual and atlas 2011, Thieme, Stuttgart (Germany).
49. Koegelenberg C.F., Diacon A.H. Pleural controversy: closed needle pleural biopsy or thoracoscopy -which first?. Respirology 2011, 16:738-746.
50. Wrightson J.M., Davies H.E. Outcome of patients with nonspecific pleuritis at thoracoscopy. Curr Opin Pulm Med 2011, 17:242-246.
51. Du Rand I., Maskell N. Introduction and methods: British Thoracic Society pleural disease guideline 2010. Thorax 2010, 65(Suppl 2):ii1-ii3.
52. Colice G.L., Curtis A., Deslauriers J., et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000, 118:1158-1171.
53. Antony V.B., Loddenkemper R., Astoul P., et al. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000, 162:1987-2001.
54. Pistoria M.J., Amin A.N., Dressler D.D., et al. The core competencies in hospital medicine. JHosp Med 2006, 1(Suppl 1):54-55.
55. Havelock T., Teoh R., Laws D., et al. Pleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2010. Thorax 2010, 65(Suppl 2):ii61-ii76.
56. Duncan D.R., Morgenthaler T.I., Ryu J.H., et al. Reducing iatrogenic risk in thoracentesis. Establishing best practice via experiential training in a zero-risk environment. Chest 2009, 135:1315-1320.
57. Mayo P.H., Beaulieu Y., Doelken P., et al. American College of Chest Physicians/La Société de Réanimation de Langue Française statement on competence in critical care ultrasonography. Chest 2009, 135:1050-1060.
58. Faculty of Clinical Radiology Ultrasound training recommendations for medical and surgical specialties 2005, The Royal College of Radiologists, London.